Last checked at 
LONDON, June 29 (Reuters) - The rush to large-cap, highquality, dividend-paying pharmaceutical stocks in the aftermathof Brexit has helped Europe's healthcare index erase allits losses since last week's vote.
The healthcare index, up 1.4 percent on Wednesday, is theonly regional sector index to trade above last Thursday's close.
Gains were led by British pharma stocks such as AstraZeneca and GlaxoSmithKline, both up 10.5 percent and7.5 percent, in the past three sessions.
A weaker sterling further adds to the UK large-caphealthcare sector's appeal given that a significant share oftheir revenues comes from outside Britain.
(Reporting by Vikram Subhedar; Editing by Sudip Kar-Gupta)
